In conclusion, our results suggest that targeting TRPV4/NOX4 signaling may provide a new therapy for lung remodeling in asthma in situations where treatments focused solely on steroids or other conventional treatments have proven ineffective. The gene discussed is NOX4; the disease is asthma.